Home
Conditions
Recurrent Mycosis Fungoides/Sezary Syndrome

Clinical trial condition

Recurrent Mycosis Fungoides/Sezary Syndrome

Explore clinical trials studying Recurrent Mycosis Fungoides/Sezary Syndrome. Study availability and eligibility vary by location and protocol.

55 public trials 0 recruiting studies

Refine in advanced search Browse all conditions

Recurrent Mycosis Fungoides/Sezary Syndrome trial results

Completed

Vorinostat in Treating Patients With Metastatic or Unresectable Solid Tumors or Lymphoma and Liver Dysfunction

NCT00499811

Conditions: Adult Grade III Lymphomatoid Granulomatosis, Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, +112 more
Locations: City of Hope Medical Center Duarte, California, United States

University of Southern California Los Angeles, California, United States

Emory University/Winship Cancer Institute Atlanta, Georgia, United States

National Institutes of Health Bethesda, Maryland, United States

View Trial Details

Completed

Bevacizumab and Cediranib Maleate in Treating Patients With Metastatic or Unresectable Solid Tumor, Lymphoma, Intracranial Glioblastoma, Gliosarcoma or Anaplastic Astrocytoma

NCT00458731

Conditions: Adult Grade III Lymphomatoid Granulomatosis, Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, +116 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

FAU in Treating Patients With Advanced Solid Tumors or Lymphoma

NCT00769288

Conditions: Adult Grade III Lymphomatoid Granulomatosis, Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, +107 more
Locations: Wayne State University Detroit, Michigan, United States

View Trial Details

Completed

Bortezomib and Azacitidine in Treating Patients With Relapsed or Refractory T-Cell Lymphoma

NCT01129180

Conditions: Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, +35 more
Locations: Ohio State University Medical Center Columbus, Ohio, United States

View Trial Details

Completed

3-AP and Gemcitabine in Treating Patients With Advanced Solid Tumors or Lymphoma

NCT00293345

Conditions: Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, Blood Protein Disorders, +107 more
Locations: Ohio State University Medical Center Columbus, Ohio, United States

View Trial Details

Completed

PXD101 and Bortezomib in Treating Patients With Advanced Solid Tumors or Lymphomas

NCT00348985

Conditions: Adult Grade III Lymphomatoid Granulomatosis, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, +109 more
Locations: University of Colorado Denver, Colorado, United States

View Trial Details

Completed

17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Advanced Epithelial Cancer, Malignant Lymphoma, or Sarcoma

NCT00004241

Conditions: AIDS-related Peripheral/Systemic Lymphoma, AIDS-related Primary CNS Lymphoma, Anaplastic Large Cell Lymphoma, +105 more
Locations: University of Pittsburgh Pittsburgh, Pennsylvania, United States

View Trial Details

Completed

Imatinib Mesylate in Treating Patients With Advanced Cancer and Liver Dysfunction

NCT00025415

Conditions: AIDS-related Peripheral/Systemic Lymphoma, AIDS-related Primary CNS Lymphoma, Accelerated Phase Chronic Myelogenous Leukemia, +170 more
Locations: University of Pittsburgh Pittsburgh, Pennsylvania, United States

View Trial Details

Completed

17-DMAG in Treating Patients With Metastatic or Unresectable Solid Tumors or Lymphomas

NCT00089271

Conditions: Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, Blood Protein Disorders, +97 more
Locations: University of Pittsburgh Pittsburgh, Pennsylvania, United States

View Trial Details

Completed

MS-275 and Isotretinoin in Treating Patients With Metastatic or Advanced Solid Tumors or Lymphomas

NCT00098891

Conditions: Adult Grade III Lymphomatoid Granulomatosis, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, +92 more
Locations: Johns Hopkins University Baltimore, Maryland, United States

View Trial Details

Recurrent Mycosis Fungoides/Sezary Syndrome

Recurrent Mycosis Fungoides/Sezary Syndrome trial results

Related conditions